Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain CM Cassidy, FA Zucca, RR Girgis, SC Baker, JJ Weinstein, ME Sharp, ... Proceedings of the National Academy of Sciences 116 (11), 5108-5117, 2019 | 205 | 2019 |
Dopamine selectively remediates ‘model-based’reward learning: a computational approach ME Sharp, K Foerde, ND Daw, D Shohamy Brain 139 (2), 355-364, 2016 | 148 | 2016 |
Dexamethasone in Cryptococcus gattii Central Nervous System Infection P Phillips, K Chapman, M Sharp, P Harrison, J Vortel, T Steiner, W Bowie Clinical infectious diseases 49 (4), 591-595, 2009 | 60 | 2009 |
The Quebec Parkinson network: a researcher-patient matching platform and multimodal biorepository Z Gan-Or, T Rao, E Leveille, C Degroot, S Chouinard, F Cicchetti, ... Journal of Parkinson's disease 10 (1), 301-313, 2020 | 49 | 2020 |
The impact of pandemic-related worry on cognitive functioning and risk-taking K da Silva Castanheira, M Sharp, AR Otto PloS one 16 (11), e0260061, 2021 | 40 | 2021 |
Sensitivity and bias in decision-making under risk: Evaluating the perception of reward, its probability and value ME Sharp, J Viswanathan, LJ Lanyon, JJS Barton PLoS One 7 (4), e33460, 2012 | 35 | 2012 |
Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation ME Sharp, KS Marder, L Côté, LN Clark, WC Nichols, JP Vonsattel, ... Movement Disorders 29 (4), 566-568, 2014 | 30 | 2014 |
Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers D Vilas, M Sharp, E Gelpi, D Genís, KS Marder, E Cortes, JP Vonsattel, ... Movement disorders: official journal of the Movement Disorder Society 33 (2 …, 2018 | 26 | 2018 |
Stem cell transplantation for adult-onset krabbe disease: report of a case ME Sharp, C Laule, S Nantel, B Mädler, RB Aul, S Yip, S Sirrs JIMD Reports-Volume 10, 57-59, 2013 | 25 | 2013 |
The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD study ME Sharp, E Caccappolo, H Mejia‐Santana, MX Tang, L Rosado, ... Movement Disorders 30 (2), 278-283, 2015 | 23 | 2015 |
Dopamine is associated with prioritization of reward-associated memories in Parkinson’s disease ME Sharp, K Duncan, K Foerde, D Shohamy Brain 143 (8), 2519-2531, 2020 | 19 | 2020 |
Decisions under risk in Parkinson’s disease: Preserved evaluation of probability and magnitude ME Sharp, J Viswanathan, MJ McKeown, S Appel-Cresswell, AJ Stoessl, ... Neuropsychologia 51 (13), 2679-2689, 2013 | 17 | 2013 |
The association of age-related and off-target retention with longitudinal quantification of [18F] MK6240 tau PET in target regions C Tissot, S Servaes, FZ Lussier, JP Ferrari-Souza, J Therriault, ... Journal of Nuclear Medicine 64 (3), 452-459, 2023 | 11 | 2023 |
Preserved motor memory in Parkinson's disease S Lahlou, E Gabitov, L Owen, D Shohamy, M Sharp Neuropsychologia 167, 108161, 2022 | 11 | 2022 |
The neurophysiological brain-fingerprint of Parkinson’s disease J da Silva Castanheira, AI Wiesman, JY Hansen, B Misic, S Baillet, ... EBioMedicine 105, 2024 | 9 | 2024 |
Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson’s patients M Bogdanov, S LoParco, AR Otto, M Sharp Neurobiology of Learning and Memory 193, 107652, 2022 | 8 | 2022 |
Immunomodulation in adult epilepsy: the role of IVIG M Sharp, M Javidan Canadian journal of neurological sciences 39 (5), 584-591, 2012 | 7 | 2012 |
Applause sign in clinically overlapping diseases: A case of TDP-43 proteinopathy D Arkadir, PE Greene, CH Waters, CB Moskowitz, ME Sharp Parkinsonism & Related Disorders 19 (8), 774-775, 2013 | 6 | 2013 |
Exploring reward-related attention selectivity deficits in Parkinson’s disease MJD Pilgrim, ZYA Ou, M Sharp Scientific Reports 11 (1), 18751, 2021 | 4 | 2021 |
Genetics and cognition in Parkinson’s disease ME Sharp, RN Alcalay Clinical Neuropsychology and Cognitive Neurology of Parkinson’s Disease and …, 2015 | 3 | 2015 |